LARGE HEMISPHERIC STROKE RESULTS IN BRAIN EDEMA
BIOLOGY OF AQUAPORINS
Neuromyelitis Optica (NMO)
Novel compounds targeting key driver of edema in several clinical indications
Aquaporin 4 (AQP4) inhibitors based on novel structure-based inhibitor design
Our relationships with our partners allow us to build prospective pipelines as well as evaluate new technologies that augment our discovery and development initiatives.
Screening campaign yielded multiple highly potent AQP4 inhibitors
Compounds have opportunity to treat several edema-related disorders